BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2022 2:41:53 AM | Browse: 743 | Download: 1610
Publication Name World Journal of Virology
Manuscript ID 74465
Country Nigeria
ISSN 2220-3249 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Virology
Manuscript Type Minireviews
Article Title SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape
Manuscript Source Invited Manuscript
All Author List Adekunle Sanyaolu, Aleksandra Marinkovic, Stephanie Prakash, Nafees Haider, Martina Williams, Chuku Okorie, Olanrewaju Badaru and Stella Smith
ORCID
Author(s) ORCID Number
Adekunle Sanyaolu http://orcid.org/0000-0002-6265-665X
Aleksandra Marinkovic http://orcid.org/0000-0002-3672-0777
Stephanie Prakash http://orcid.org/0000-0003-2664-9775
Nafees Haider http://orcid.org/0000-0003-4449-0905
Martina Williams http://orcid.org/0000-0001-5136-4179
Chuku Okorie http://orcid.org/0000-0001-5483-0032
Olanrewaju Badaru http://orcid.org/0000-0003-3035-2640
Stella Smith http://orcid.org/0000-0003-2163-1189
Funding Agency and Grant Number
Corresponding Author Adekunle Sanyaolu, PhD, Academic Research, Director, Director, Department of Public Health, Federal Ministry of Health, New Federal Secretariat Complex, Phase III, Ahmadu Bello Way, Central Business District, Abuja 0000, Nigeria. sanyakunle@hotmail.com
Key Words SARS-CoV-2; COVID-19; Omicron; B.1.1.529; Variant of concern; Emerging variants
Core Tip The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, Omicron (B.1.1.529), was first reported to World Health Organization from South Africa on November 24, 2021. Omicron has been labeled a variant of concern because of genetic changes that increase transmissibility and decrease the effectiveness of health measures, vaccines, and therapeutics. This variant has 32 mutations in the spike protein, which is problematic because vaccinations designed to prevent SARS-CoV-2 infections target spike proteins. Despite some evidence that vaccination alone may not be enough, non-pharmaceutical practices such as continued use of face masks, proper hygiene precautions, and social distancing, are required to successfully combat this variant.
Publish Date 2022-05-20 02:41
Citation Sanyaolu A, Marinkovic A, Prakash S, Haider N, Williams M, Okorie C, Badaru O, Smith S. SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape. World J Virol 2022; 11(3): 137-143
URL https://www.wjgnet.com/2220-3249/full/v11/i3/137.htm
DOI https://dx.doi.org/10.5501/wjv.v11.i3.137
Full Article (PDF) WJV-11-137.pdf
Full Article (Word) WJV-11-137.docx